​

Subtitle: 

Investigating the effects of high-dose mineralocorticoid receptor antagonist in patients with type 2 diabetes and increased cardiovascular risk

Ph.d. Defence:

• Niels H. Brandt-Jacobsen, MD
  

Principal Supervisor: 

• Professor Caroline M. Kistorp, MD, Ph.d.
  

​​Principal co-supervisors: 

• Professor Morten Schou, MD, Ph.d.
  

​Additional supervisors: 

• Professor emeritus Jens Faber, MD, DMSc
• Associate professor Per Lau Madsen, MD, DMSc
  
  

Assessment Committee:

• Associate professor Peter Lommer Kristensen (Chair of the committee)
  Department of Clinical Medicine, Copenhagen University, Department of Cardiology, Nephrology and Endocrinology, Hillerød University Hospital. 
  

• Professor Mark Petri
  School of Cardivovascular and Metabolic Health University of Glasgow, Glasgow
  

• Associate professor Esben Søndergaard
  Department of Clinical Medicine, Aarhus University Steno Diabetes Center, Århus